600535.SS
600535.SS
CNE000001C81
TASLY PHARMACEUTICAL GROUP CO L
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
21.21B EUR
19.76B EUR
21.44B EUR
Enterprise Value
17.88B EUR
19.24B EUR
21.96B EUR
Valuation Multiples
Trailing P/E
17.32x
13.41x
16.94x
Forward P/E
14.95x
--
--
Price to Sales
2.6x
2.36x
2.56x
Price to Book
1.62x
1.51x
1.68x
EV/Revenue
2.19x
2.3x
2.62x
EV/EBITDA
9.18x
11.17x
14.72x
Price to FCF (P/FCF)
15.25x
7.78x
15.41x
EV/FCF
12.85x
7.58x
15.78x
FCF Yield
6.56%
12.85%
6.49%
ende